Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PAL who wrote (4219)	5/5/1998 12:18:00 PM
From: sam	Read Replies (1) of 6136

Keep in mind there are a lot of people with a lot of money (anybody know what Tiger Management's position now is?) who will spend that money to keep AGPH's share price low enough either to stifle any rally or to get out themselves. The good news (for shareholders) is that the prospects for AG3340 (or any of AGPH's compounds other than Viracept) are not reflected in AGPH's stock price...yet. And It's always nice to see AGPH get some CNBC exposure as well.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next